好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C159 - Behavioral Management of Dementia

Tuesday 04/28/20
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Julio C. Rojas-Martinez, MD, PhD
Aging, Dementia, and Behavioral Neurology
Participants should have increased knowledge to use behavioral interventions as a first line of treatment for the management of common symptoms of dementia, such as resistance to care, paranoia, anger, wandering, anxiety, sundowning, and disinhibition; skills to effectively complete the semiology of difficult neurobehavioral symptoms of dementia; and competencies to counsel and coach caregivers on techniques to improve behaviors. Attendees will identify barriers and potential solutions for the effective implementation of behavioral strategies in dementia.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Systems-based Practice
Introductory
Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student
Case-based, Didactic, Audience Participation
Event Timeline
03:30 PM - 04:05 PM Speaker The Dementia Ecosystem: Skills and Competencies around the Patient, the Caregiver, and the Environment
Julio C. Rojas-Martinez, MD, PhD
04:05 PM - 04:40 PM Speaker DICE: A Systematic Approach to Behavioral Management in Dementia
04:40 PM - 05:15 PM Speaker Behavioral Management of Specific Cognitive, Affective, and Behavioral Symptoms in Dementia: Clinical Cases
Mary E. Quiceno, MD, FAAN
05:15 PM - 05:30 PM Q&A Questions and Answers
Faculty Disclosures
Julio C. Rojas-Martinez, MD, PhD Dr. Rojas-Martinez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ferrer International, S.A.. The institution of Dr. Rojas-Martinez has received research support from NIH/NIA. The institution of Dr. Rojas-Martinez has received research support from Eli Lilly. The institution of Dr. Rojas-Martinez has received research support from Eisai. The institution of Dr. Rojas-Martinez has received research support from Amylyx.
Mary E. Quiceno, MD, FAAN Dr. Quiceno has received personal compensation for serving as an employee of Prothena Biosciences. Dr. Quiceno has received personal compensation for serving as an employee of Johnson & Johnson. Dr. Quiceno has stock in Prothena Biosciences. Dr. Quiceno has stock in Johnson & Johnson.
No disclosure on file